{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:12:24Z","timestamp":1778127144523,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P20NS123151-01"],"award-info":[{"award-number":["P20NS123151-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10571-023-01334-8","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T05:02:49Z","timestamp":1679547769000},"page":"3037-3046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Pilot Study of Ex Vivo Human Prefrontal RNA Transcriptomics in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Li-Chun","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel C.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy D. W.","family":"Greenlee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandakumar S.","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"1334_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1750-3639.2009.00369.x","volume":"20","author":"D Aarsland","year":"2010","unstructured":"Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson\u2019s disease. Brain Pathol 20:633\u2013639","journal-title":"Brain Pathol"},{"key":"1334_CR2","doi-asserted-by":"publisher","first-page":"104872","DOI":"10.1016\/j.nbd.2020.104872","volume":"140","author":"SM Benoit","year":"2020","unstructured":"Benoit SM, Xu H, Schmid S, Alexandrova R, Kaur G et al (2020) Expanding the search for genetic biomarkers of Parkinson\u2019s disease into the living brain. Neurobiol Dis 140:104872","journal-title":"Neurobiol Dis"},{"key":"1334_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s004010000247","volume":"101","author":"E Braak","year":"2001","unstructured":"Braak E, Sandmann-Keil D, Rub U, Gai WP, de Vos RA et al (2001) alpha-synuclein immunopositive Parkinson\u2019s disease-related inclusion bodies in lower brain stem nuclei. Acta Neuropathol 101:195\u2013201","journal-title":"Acta Neuropathol"},{"key":"1334_CR4","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404\u20131410","journal-title":"Neurology"},{"key":"1334_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jns.2006.05.011","volume":"248","author":"H Braak","year":"2006","unstructured":"Braak H, Rub U, Del Tredici K (2006) Cognitive decline correlates with neuropathological stage in Parkinson\u2019s disease. J Neurol Sci 248:255\u2013258","journal-title":"J Neurol Sci"},{"key":"1334_CR6","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1093\/cercor\/bhz209","volume":"30","author":"M Co","year":"2020","unstructured":"Co M, Hickey SL, Kulkarni A, Harper M, Konopka G (2020) Cortical Foxp2 supports behavioral flexibility and developmental dopamine D1 receptor expression. Cereb Cortex 30:1855\u20131870","journal-title":"Cereb Cortex"},{"key":"1334_CR7","doi-asserted-by":"crossref","unstructured":"Cole RC, Espinoza AI, Singh A, Berger JI, Cavanagh JF et al (2022) Novelty-induced frontal-STN networks in Parkinson\u2019s disease. Cereb Cortex","DOI":"10.1101\/2021.06.24.21259502"},{"key":"1334_CR8","doi-asserted-by":"crossref","unstructured":"Davis AP, Wiegers TC, Johnson RJ, Sciaky D, Wiegers J, Mattingly CJ (2022) Comparative Toxicogenomics Database (CTD): update 2023. Nucleic Acids Res","DOI":"10.1093\/nar\/gkac833"},{"key":"1334_CR9","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1073\/pnas.1214546110","volume":"110","author":"C de Hemptinne","year":"2013","unstructured":"de Hemptinne C, Ryapolova-Webb ES, Air EL, Garcia PA, Miller KJ et al (2013) Exaggerated phase-amplitude coupling in the primary motor cortex in Parkinson disease. Proc Natl Acad Sci USA 110:4780\u20134785","journal-title":"Proc Natl Acad Sci USA"},{"key":"1334_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF01245232","volume":"91","author":"AY Deutch","year":"1993","unstructured":"Deutch AY (1993) Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson\u2019s disease. J Neural Transm Gen Sect 91:197\u2013221","journal-title":"J Neural Transm Gen Sect"},{"key":"1334_CR11","doi-asserted-by":"publisher","first-page":"e1002794","DOI":"10.1371\/journal.pgen.1002794","volume":"8","author":"A Dumitriu","year":"2012","unstructured":"Dumitriu A, Latourelle JC, Hadzi TC, Pankratz N, Garza D et al (2012) Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation. PLoS Genet 8:e1002794","journal-title":"PLoS Genet"},{"key":"1334_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.tig.2009.03.002","volume":"25","author":"SE Fisher","year":"2009","unstructured":"Fisher SE, Scharff C (2009) FOXP2 as a molecular window into speech and language. Trends Genet 25:166\u2013177","journal-title":"Trends Genet"},{"key":"1334_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nbt1385","volume":"26","author":"GK Geiss","year":"2008","unstructured":"Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N et al (2008) Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26:317\u2013325","journal-title":"Nat Biotechnol"},{"key":"1334_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-021-00439-2","volume":"16","author":"M Gries","year":"2021","unstructured":"Gries M, Christmann A, Schulte S, Weyland M, Rommel S et al (2021) Parkinson mice show functional and molecular changes in the gut long before motoric disease onset. Mol Neurodegener 16:34","journal-title":"Mol Neurodegener"},{"key":"1334_CR15","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1212\/WNL.51.2_Suppl_2.S2","volume":"51","author":"O Hornykiewicz","year":"1998","unstructured":"Hornykiewicz O (1998) Biochemical aspects of Parkinson\u2019s disease. Neurology 51:S2-9","journal-title":"Neurology"},{"key":"1334_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368\u2013376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1334_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1266\/ggs.18-00036","volume":"94","author":"J Li","year":"2019","unstructured":"Li J, Sun Y, Chen J (2019) Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson\u2019s disease. Genes Genet Syst 94:61\u201369","journal-title":"Genes Genet Syst"},{"key":"1334_CR18","doi-asserted-by":"publisher","first-page":"679568","DOI":"10.3389\/fnins.2021.679568","volume":"15","author":"B Li","year":"2021","unstructured":"Li B, Zhao G, Zhou Q, Xie Y, Wang Z et al (2021) Gene4PD: a comprehensive genetic database of Parkinson\u2019s disease. Front Neurosci 15:679568","journal-title":"Front Neurosci"},{"key":"1334_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbr.2014.02.039","volume":"266","author":"Y Ma","year":"2014","unstructured":"Ma Y, Zhan M, OuYang L, Li Y, Chen S et al (2014) The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats. Behav Brain Res 266:37\u201345","journal-title":"Behav Brain Res"},{"key":"1334_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S et al (2019) Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570:332\u2013337","journal-title":"Nature"},{"key":"1334_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1006\/exnr.2000.7441","volume":"164","author":"A Mura","year":"2000","unstructured":"Mura A, Feldon J, Mintz M (2000) The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment. Exp Neurol 164:322\u2013332","journal-title":"Exp Neurol"},{"key":"1334_CR22","first-page":"457","volume":"269","author":"NS Narayanan","year":"2022","unstructured":"Narayanan NS, Albin RL (2022) The way forward for cognition in Parkinson\u2019s disease. Cogn Parkinson\u2019s Dis 269:457","journal-title":"Cogn Parkinson\u2019s Dis"},{"key":"1334_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1515\/revneuro-2013-0004","volume":"24","author":"NS Narayanan","year":"2013","unstructured":"Narayanan NS, Rodnitzky RL, Uc EY (2013) Prefrontal dopamine signaling and cognitive symptoms of Parkinson\u2019s disease. Rev Neurosci 24:267\u2013278","journal-title":"Rev Neurosci"},{"key":"1334_CR24","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S1471-1931(00)00028-8","volume":"23","author":"JA Obeso","year":"2000","unstructured":"Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J et al (2000) Pathophysiology of the basal ganglia in Parkinson\u2019s disease. Trends Neurosci 23:S8-19","journal-title":"Trends Neurosci"},{"key":"1334_CR25","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","volume":"36","author":"H Qin","year":"2016","unstructured":"Qin H, Buckley JA, Li X, Liu Y, Fox TH 3rd et al (2016) Inhibition of the JAK\/STAT pathway protects against alpha-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J Neurosci 36:5144\u20135159","journal-title":"J Neurosci"},{"key":"1334_CR26","doi-asserted-by":"crossref","unstructured":"Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, et al. 2016. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database","DOI":"10.1093\/database\/baw100"},{"key":"1334_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41531-021-00158-x","volume":"7","author":"A Singh","year":"2021","unstructured":"Singh A, Cole RC, Espinoza AI, Evans A, Cao S et al (2021) Timing variability and midfrontal ~4 Hz rhythms correlate with cognition in Parkinson\u2019s disease. NPJ Parkinsons Dis 7:14","journal-title":"NPJ Parkinsons Dis"},{"key":"1334_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S et al (2003) alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841","journal-title":"Science"},{"key":"1334_CR29","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95:6469\u20136473","journal-title":"Proc Natl Acad Sci USA"},{"key":"1334_CR30","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/mds.22184","volume":"23","author":"C Stamper","year":"2008","unstructured":"Stamper C, Siegel A, Liang WS, Pearson JV, Stephan DA et al (2008) Neuronal gene expression correlates of Parkinson\u2019s disease with dementia. Mov Disord 23:1588\u20131595","journal-title":"Mov Disord"},{"key":"1334_CR31","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1474-4422(07)70246-6","volume":"6","author":"DJ Surmeier","year":"2007","unstructured":"Surmeier DJ (2007) Calcium, ageing, and neuronal vulnerability in Parkinson\u2019s disease. Lancet Neurol 6:933\u2013938","journal-title":"Lancet Neurol"},{"key":"1334_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/01.WCB.0000034148.72481.F4","volume":"22","author":"Y Takagi","year":"2002","unstructured":"Takagi Y, Harada J, Chiarugi A, Moskowitz MA (2002) STAT1 is activated in neurons after ischemia and contributes to ischemic brain injury. J Cereb Blood Flow Metab 22:1311\u20131318","journal-title":"J Cereb Blood Flow Metab"},{"key":"1334_CR33","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1093\/brain\/awp245","volume":"132","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M et al (2009) The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958\u20132969","journal-title":"Brain"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01334-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-023-01334-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01334-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T16:16:42Z","timestamp":1689005802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-023-01334-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1007\/s10571-023-01334-8","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}